43.00 +0.00 (0.00%)
CGRB
Stock Details
Last Trade:43.00 Change:+0.00 (0.00%) Prev Close:43.00 Open: 42.98 Days Range:42.98 – 43.02 52 Week Range: 16.35 - 45.00 Volume:130432 P/E: N/AEPS:-2.90
View AllRecent Alerts 07/04/09
Recent Alert on 05/22/09 at 12:24pm
Unusual 11 Mid-Day Movers 5/22: OXGN, SEED, ARUN, BBOX Higher; ATAC, RRGB, GM, ZUMZ Lower
Unusual 11 Mid-Day Movers 5/22: OXGN, SEED, ARUN, BBOX Higher; ATAC, RRGB, GM, ZUMZ Lower
OXiGENE, Inc. (Nasdaq: OXGN) 29.6% HIGHER; trading higher in anticipation of data on ZYBRESTAT following news last night that OXiGENE will issue that results from a Phase 2 clinical trial on the candidate at the upcoming 2009 Annual Meeting of the... Read More
Recent Alert on 05/22/09 at 10:16am
Notable Mergers and Acquisitions of the Day 5/22: JNJ/CGRB, PLA, AMSWA/LGTY
Notable Mergers and Acquisitions of the Day 5/22: JNJ/CGRB, PLA, AMSWA/LGTY
Recent Alert on 05/22/09 at 9:29am
Morning Movers 5/22: AMSWA, SHLD, ARUN, AIB, OGXI, CGRB, ADSK Higher; ZUMZ, RRGB, CRM Lower
Morning Movers 5/22: AMSWA, SHLD, ARUN, AIB, OGXI, CGRB, ADSK Higher; ZUMZ, RRGB, CRM Lower
Recent Alert on 05/22/09 at 8:13am
Dendreon (DNDN) and OncoGenex (OGXI) Could See Interest On JNJ's Cougar Biotech Deal
Dendreon (DNDN) and OncoGenex (OGXI) Could See Interest On JNJ's Cougar Biotech Deal
Recent Alert on 05/22/09 at 8:13am
Dendreon (DNDN) and OncoGenex (OGXI) Could See Interest On JNJ's Cougar Biotech Deal
Dendreon (DNDN) and OncoGenex (OGXI) Could See Interest On JNJ's Cougar Biotech Deal
View AllRecent Press Releases
Press Release on 07/03/09 at 12:00pm
Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period
Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period
Press Release on 07/03/09 at 8:53am
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
View AllRecent SEC Filings
SEC Filing on 06/30/09 at 4:04pm
Form SC 13D Cougar Biotechnology, Filed by: GAMCO INVESTORS, INC. ET AL
Form SC 13D Cougar Biotechnology, Filed by: GAMCO INVESTORS, INC. ET AL
View AllRecent Blog Posts
Blog Posts on 06/19/09 at 8:36am
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer